In this episode (in Swiss German), host Angelina Rau sits down with Barbara Meier, attorney at law at VISCHER AG and expert in tariff and healthcare law, to unpack one of the most complex yet crucial topics for digital health innovators in Switzerland — reimbursement and tariffs. They discuss how Digital Health Applications (DiGAs) — software-based medical devices such as health apps or digital therapeutics — gain access to the Swiss healthcare system. Even when approved and recognized under ...
All content for Navigating Swiss Market Access #medtech #digitalhealth is the property of Gurmit Sandhu & Angelina Rau and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode (in Swiss German), host Angelina Rau sits down with Barbara Meier, attorney at law at VISCHER AG and expert in tariff and healthcare law, to unpack one of the most complex yet crucial topics for digital health innovators in Switzerland — reimbursement and tariffs. They discuss how Digital Health Applications (DiGAs) — software-based medical devices such as health apps or digital therapeutics — gain access to the Swiss healthcare system. Even when approved and recognized under ...
Episode 2: How can your Digital Health Technology (DHT) be reimbursed in Swizerland?
In this episode, we explore the reimbursement landscape for digital health technologies (DHTs) in Switzerland with Angelina, offering an introductory overview of key pathways to market access. We focus on the inclusion of DHTs in Switzerland’s compulsory health insurance system ("OKP") and touch on the essential reimbursement criteria—known as the "EAE criteria" or "WZW-Kriterien": Effectiveness (Wirksamkeit)Appropriateness (Zweckmässigkeit)Cost-effectiveness (Wirtschaftlichkeit)We also highl...
In this episode (in Swiss German), host Angelina Rau sits down with Barbara Meier, attorney at law at VISCHER AG and expert in tariff and healthcare law, to unpack one of the most complex yet crucial topics for digital health innovators in Switzerland — reimbursement and tariffs. They discuss how Digital Health Applications (DiGAs) — software-based medical devices such as health apps or digital therapeutics — gain access to the Swiss healthcare system. Even when approved and recognized under ...
